NCT04708457View on ClinicalTrials.gov

The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

December 31, 2022

Conditions
Mechanical Ventilation ComplicationSevere Acute Respiratory InfectionCovid19
Interventions
OTHER

VV-ECMO

Early use of VV-ECMO in SARI patients.

Trial Locations (2)

3004

The Alfred Hospital, Melbourne

10117

Charite Universitatmedizin, Berlin

All Listed Sponsors
collaborator

The Alfred

OTHER

lead

Australian and New Zealand Intensive Care Research Centre

OTHER

NCT04708457 - The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO | Biotech Hunter | Biotech Hunter